Oramed Reports Positive Top-Line Results from Phase 2 NASH Trial with its ORMD-0801, Oral Insulin Candidate September 13, 2022 Press Releases
Fierce Biotech: Oramed phase 2 insulin drug data ‘paint an exciting picture’ in rocky NASH landscape September 13, 2022 In the News
Oramed to Present at H.C. Wainwright 24th Annual Global Investment Conference September 6, 2022 Press Releases
Benzinga: This Company Says Its Developing a COVID-19 Vaccine That Can be Taken Orally July 25, 2022 In the News
Oramed to Present at the Upcoming Canaccord Genuity Annual Growth Conference July 11, 2022 Press Releases